Patients with one of the deadliest cancers have been pleading for an unapproved treatment that may prolong their lives.
F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer
The New York Times – Business:
This post first appeared in The New York Times – Business. Read the original article.
Written by
in
Leave a Reply